Amivantamab: A Potent Novel EGFR/c-MET Bispecific Antibody Therapy for EGFR-mutated Non-small Cell Lung Cancer. Issue 1 (2021) - Guo, Matthew Z; Marrone, Kristen A; Spira, Alexander; Freeman, Kristine; Scott, Susan C
No abstract available